Stockreport

Patients rushing to join studies of promising coronavirus drug [CBS News]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences' remdesivir is farther along in testing than many other potential therapies and the studies could lead to regulatory approval. [Read more]